9.88 USD
↘ 0.92 (8.56%)LIVE (AS OF 11:46 AM EDT)
Climb Bio, Inc. Common Stock
CLYMNASDAQ • USD
Market: OPEN
Open?$10.80
High?$11.12
Low?$9.78
Prev. Close?$10.80
Volume?259.9K
Avg. Volume?830.7K
VWAP?$10.17
Rel. Volume?0.31x
Bid / Ask
Bid?$9.82 × 100
Ask?$9.88 × 100
Spread?$0.06
Midpoint?$9.85
Valuation & Ratios
Market Cap?618.4M
Shares Out?57.3M
Float?20.0M
Float %?41.8%
P/E Ratio?N/A
P/B Ratio?4.18
EPS?-$0.92
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Climb Bio Inc is a clinical-stage biotechnology company focused on developing therapeutics for patients with immune-mediated diseases. Its pipeline includes Budoprutug, an anti-CD19 monoclonal antibody being developed for B-cell mediated diseases such as primary membranous nephropathy, immune thrombocytopenia, and systemic lupus erythematosus, and CLYM116, an anti-APRIL monoclonal antibody being developed for the treatment of IgA nephropathy.
Themes
Employees
29
Market Cap
618.4M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2021-08-10
Address
20 WILLIAM STREET
WELLESLEY HILLS, MA 02481
Phone: 1-866-857-2596
WELLESLEY HILLS, MA 02481
Phone: 1-866-857-2596
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?27.86Strong
Quick Ratio?27.86Strong
Cash Ratio?2.05Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUED
Score83/100
P/E?N/A▾
P/B?4.18FAIR▾
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-10.2CHEAP▾
EV/Sales?N/A▾
Returns & Efficiency
ROE?-35.7%WEAK▾
ROA?-34.7%WEAK▾
Cash Flow & Enterprise
FCF?$-53487000
Enterprise Value?$610.1M
Fundamentals ratios updated end of day